Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Toxins (Basel) ; 11(7)2019 07 14.
Article in English | MEDLINE | ID: mdl-31337106

ABSTRACT

Aflatoxins continue to be a food safety problem globally, especially in developing regions. A significant amount of effort and resources have been invested in an attempt to control aflatoxins. However, these efforts have not substantially decreased the prevalence nor the dietary exposure to aflatoxins in developing countries. One approach to aflatoxin control is the use of binding agents in foods, and lactic acid bacteria (LAB) have been studied extensively for this purpose. However, when assessing the results comprehensively and reviewing the practicality and ethics of use, risks are evident, and concerns arise. In conclusion, our review suggests that there are too many issues with using LAB for aflatoxin binding for it to be safely promoted. Arguably, using binders in human food might even worsen food safety in the longer term.


Subject(s)
Aflatoxins/chemistry , Food Contamination/prevention & control , Food Safety , Lactobacillales/chemistry , Developing Countries , Humans , Kenya
2.
Toxins (Basel) ; 10(9)2018 08 29.
Article in English | MEDLINE | ID: mdl-30158473

ABSTRACT

Aflatoxin M1 (AFM1), a human carcinogen, is found in milk products and may have potentially severe health impacts on milk consumers. We assessed the risk of cancer and stunting as a result of AFM1 consumption in Nairobi, Kenya, using worst case assumptions of toxicity and data from previous studies. Almost all (99.5%) milk was contaminated with AFM1. Cancer risk caused by AFM1 was lower among consumers purchasing from formal markets (0.003 cases per 100,000) than for low-income consumers (0.006 cases per 100,000) purchasing from informal markets. Overall cancer risk (0.004 cases per 100,000) from AFM1 alone was low. Stunting is multifactorial, but assuming only AFM1 consumption was the determinant, consumption of milk contaminated with AFM1 levels found in this study could contribute to 2.1% of children below three years in middle-income families, and 2.4% in low-income families, being stunted. Overall, 2.7% of children could hypothetically be stunted due to AFM1 exposure from milk. Based on our results AFM1 levels found in milk could contribute to an average of -0.340 height for age z-score reduction in growth. The exposure to AFM1 from milk is 46 ng/day on average, but children bear higher exposure of 3.5 ng/kg bodyweight (bw)/day compared to adults, at 0.8 ng/kg bw/day. Our paper shows that concern over aflatoxins in milk in Nairobi is disproportionate if only risk of cancer is considered, but that the effect on stunting children might be much more significant from a public health perspective; however, there is still insufficient data on the health effects of AFM1.


Subject(s)
Aflatoxin M1/toxicity , Carcinoma, Hepatocellular/chemically induced , Food Contamination/analysis , Growth Disorders/chemically induced , Liver Neoplasms/chemically induced , Milk/chemistry , Adult , Aflatoxin M1/analysis , Animals , Child, Preschool , Dietary Exposure/adverse effects , Humans , Income , Kenya , Risk Assessment
3.
Arch Microbiol ; 199(3): 457-464, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27816987

ABSTRACT

Certain strains of lactic acid bacteria have been reported to inhibit fungal growth and may so be potential as biocontrol agents. In this study, 171 LAB strains were isolated from traditional fermented Kenyan milk and maize products and tested against aflatoxin-producing A. flavus fungi. The three LAB strains showing highest antifungal activity were identified as Lactobacillus plantarum. None of the strains were able to completely inhibit fungal growth under conditions favorable for fungi and suboptimal for LAB. These conditions probably reduced the growth and metabolic activity of some LAB isolates, as several growth-related aspects like production of antifungal biomolecules and other metabolites contribute to the inhibiting activity. The results suggest that certain LAB strains could be employed in food to control the growth of aflatoxigenic fungi. Further studies to establish the efficacy of the potential LAB strains in fermented products are in progress.


Subject(s)
Antibiosis/physiology , Aspergillus flavus/growth & development , Cultured Milk Products/microbiology , Food Microbiology , Lactobacillus/physiology , Zea mays/microbiology , Animals , Fermentation , Kenya , Lactobacillus/isolation & purification
4.
Int J Food Microbiol ; 207: 87-102, 2015 Aug 17.
Article in English | MEDLINE | ID: mdl-26001523

ABSTRACT

Aflatoxins (AF) are ubiquitous mycotoxins contaminating food and feed. Consumption of contaminated food and feed can cause a severe health risk to humans and animals. A novel biological method could reduce the health risks of aflatoxins through inhibiting mold growth and binding aflatoxins. Lactic acid bacteria (LAB) are commonly used in fermented food production. LAB are known to inhibit mold growth and, to some extent, to bind aflatoxins in different matrices. Reduced mold growth and aflatoxin production may be caused by competition for nutrients between bacterial cells and fungi. Most likely, binding of aflatoxins depends on environmental conditions and is strain-specific. Killed bacteria cells possess consistently better binding abilities for aflatoxin B1 (AFB1) than viable cells. Lactobacilli especially are relatively well studied and provide noticeable possibilities in binding of aflatoxin B1 and M1 in food. It seems that binding is reversible and that bound aflatoxins are released later on (Haskard et al., 2001; Peltonen et al., 2001). This literature review suggests that novel biological methods, such as lactic acid bacteria, show potential in mitigating toxic effects of aflatoxins in food and feed.


Subject(s)
Aflatoxins/metabolism , Food Contamination/prevention & control , Food Microbiology/methods , Lactobacillus/metabolism , Aflatoxin B1/metabolism , Animals , Fungi/metabolism , Lactobacillus/physiology , Risk , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...